Real‐world battery longevity of implantable loop recorders implanted for unexplained syncope: Results from a large single‐center registry

IF 2.3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Journal of Cardiovascular Electrophysiology Pub Date : 2024-09-10 DOI:10.1111/jce.16420
Lukas Duvillier, Anthony Demolder, Sally Van Renterghem, Caroline De Mey, Filip West, Jan De Pooter
{"title":"Real‐world battery longevity of implantable loop recorders implanted for unexplained syncope: Results from a large single‐center registry","authors":"Lukas Duvillier, Anthony Demolder, Sally Van Renterghem, Caroline De Mey, Filip West, Jan De Pooter","doi":"10.1111/jce.16420","DOIUrl":null,"url":null,"abstract":"Background/PurposeImplantable loop recorders (ILR) are increasingly used in cardiac rhythm monitoring and diagnostic work‐up of unexplained syncope. ILR battery longevity, according to manufacturers' product performance specifications, typically ranges between 2 and 4 years, but real‐world data in this population are lacking.MethodsThis monocentric, prospective, observational study included consecutive patients with unexplained syncope undergoing ILR implantation between October 2007 and 2019. The main purpose was to determine real‐world battery longevity of ILRs. Diagnostic yield and relationship between arrhythmogenic diagnosis and duration of ILR monitoring were explored.ResultsThe study included 309 patients (59 years [38–73], 49% female) with ILR implantation for unexplained syncope. Median battery longevity was 42 [40–45] months. A total of 99.5% of ILRs reached prespecified battery longevity. The time to end‐of‐life varied by up to 33 months among the same ILR models. Overall arrhythmogenic diagnostic yield counted 27% (73% sick sinus syndrome, 20% atrioventricular block, and 7% ventricular tachycardia). Median time to diagnosis was 10 [2–25] months, with the latest event at 43 months. The cumulative diagnostic yield for arrhythmogenic event explaining syncope was 4.2%, 6.1%, 9.4%, 14.6%, 19.4%, and 26.7% at 1, 2, 6, 12, 24, and 48 months, respectively. In univariate analysis, first degree AV block and prolonged HV time on EP study were predictors of diagnosis, while QRS duration abnormality borderline missed significance.ConclusionsReal‐world battery longevity of ILRs matched industry projected longevity in 99.5% of patients implanted with ILR for unexplained syncope. A battery longevity of minimum 3.5 years is recommended to maximize the diagnostic yield in this population.","PeriodicalId":15178,"journal":{"name":"Journal of Cardiovascular Electrophysiology","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiovascular Electrophysiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/jce.16420","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background/PurposeImplantable loop recorders (ILR) are increasingly used in cardiac rhythm monitoring and diagnostic work‐up of unexplained syncope. ILR battery longevity, according to manufacturers' product performance specifications, typically ranges between 2 and 4 years, but real‐world data in this population are lacking.MethodsThis monocentric, prospective, observational study included consecutive patients with unexplained syncope undergoing ILR implantation between October 2007 and 2019. The main purpose was to determine real‐world battery longevity of ILRs. Diagnostic yield and relationship between arrhythmogenic diagnosis and duration of ILR monitoring were explored.ResultsThe study included 309 patients (59 years [38–73], 49% female) with ILR implantation for unexplained syncope. Median battery longevity was 42 [40–45] months. A total of 99.5% of ILRs reached prespecified battery longevity. The time to end‐of‐life varied by up to 33 months among the same ILR models. Overall arrhythmogenic diagnostic yield counted 27% (73% sick sinus syndrome, 20% atrioventricular block, and 7% ventricular tachycardia). Median time to diagnosis was 10 [2–25] months, with the latest event at 43 months. The cumulative diagnostic yield for arrhythmogenic event explaining syncope was 4.2%, 6.1%, 9.4%, 14.6%, 19.4%, and 26.7% at 1, 2, 6, 12, 24, and 48 months, respectively. In univariate analysis, first degree AV block and prolonged HV time on EP study were predictors of diagnosis, while QRS duration abnormality borderline missed significance.ConclusionsReal‐world battery longevity of ILRs matched industry projected longevity in 99.5% of patients implanted with ILR for unexplained syncope. A battery longevity of minimum 3.5 years is recommended to maximize the diagnostic yield in this population.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
因不明原因晕厥而植入的植入式回路记录器的实际电池寿命:大型单中心登记的结果
背景/目的植入式回路记录器(ILR)越来越多地用于心律监测和不明原因晕厥的诊断工作。根据制造商的产品性能说明,ILR 的电池寿命通常在 2 到 4 年之间,但缺乏该人群的实际数据。方法这项单中心、前瞻性、观察性研究纳入了 2007 年 10 月至 2019 年期间接受 ILR 植入术的不明原因晕厥连续患者。主要目的是确定ILR在真实世界中的电池寿命。结果该研究纳入了 309 名因不明原因晕厥而接受 ILR 植入术的患者(59 岁 [38-73],49% 为女性)。中位电池寿命为 42 [40-45] 个月。99.5%的ILR达到了预设的电池寿命。同一型号的ILR寿命终止时间最多相差33个月。总体心律失常诊断率为 27%(病窦综合征 73%、房室传导阻滞 20%、室性心动过速 7%)。诊断的中位时间为 10 [2-25] 个月,最近一次诊断为 43 个月。在 1、2、6、12、24 和 48 个月时,解释晕厥的致心律失常事件的累积诊断率分别为 4.2%、6.1%、9.4%、14.6%、19.4% 和 26.7%。在单变量分析中,EP 研究中的一级房室传导阻滞和 HV 时间延长是诊断的预测因素,而 QRS 持续时间异常则未达到显著性水平。建议电池寿命至少为 3.5 年,以最大限度地提高这类人群的诊断率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.20
自引率
14.80%
发文量
433
审稿时长
3-6 weeks
期刊介绍: Journal of Cardiovascular Electrophysiology (JCE) keeps its readership well informed of the latest developments in the study and management of arrhythmic disorders. Edited by Bradley P. Knight, M.D., and a distinguished international editorial board, JCE is the leading journal devoted to the study of the electrophysiology of the heart.
期刊最新文献
Assessment of palpitations in patients with frequent premature ventricular contractions. Body mass index as a determinant of scar formation post-AF ablation: Insights from DECAAF II. Efficacy and limitation of nonparoxysmal atrial fibrillation ablation in patients with heart failure with preserved ejection fraction. Frequency and Genotype-Dependence of intrinsic chronotropic insufficiency among patients with congenital long QT syndrome. Endocardial ablation of ganglionated plexus for the treatment of carotid sinus syndrome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1